Macrogenics Stock (NASDAQ: MGNX) stock price, news, charts, stock research, profile.
Open | $4.270 |
Close | $4.090 |
Volume / Avg. | 1.805M / 2.560M |
Day Range | 4.060 - 4.410 |
52 Wk Range | 3.140 - 21.880 |
Market Cap | $259.929M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 17.42% |
Days to Cover | 1.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Macrogenics (NASDAQ: MGNX) through any online brokerage.
Other companies in Macrogenics’s space includes: Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP), Opthea (NASDAQ:OPT) and Monte Rosa Therapeutics (NASDAQ:GLUE).
The latest price target for Macrogenics (NASDAQ: MGNX) was reported by BTIG on Friday, May 24, 2024. The analyst firm set a price target for 9.00 expecting MGNX to rise to within 12 months (a possible 116.87% upside). 24 analyst firms have reported ratings in the last year.
The stock price for Macrogenics (NASDAQ: MGNX) is $4.15 last updated May 31, 2024 at 7:39 PM EDT.
There are no upcoming dividends for Macrogenics.
Macrogenics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Macrogenics.
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.